NEW YORK (Reuters) – US binds payments for COVID-19 faxes to timing miles for production and approval, according to public documents and an official from the Trump administration, putting pressure on drugmakers including Moderna Inc (MRNA.O) to meet ambitious goals. FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, …
Read More »China’s potential COVID-19 vaccine Sinopharm triggers antibodies in clinical trials: Journal
BEIJING (Reuters) – A candidate for coronavirus vaccine developed by a unit of the China National Pharmaceutical Group (Sinopharm) has been shown to be safe and trigger anti-inflammatory immune responses in early and mid-stage studies, researchers said . FILE PHOTO: The company logo of Sinopharm Group Co Ltd is displayed …
Read More »Britain regulates more potential COVID-19 vaccine products with J&J, Novavax deals
LONDON (Reuters) – Britain will buy potential COVID-19 vaccines from US drugmakers Johnson & Johnson (JNJ.N) and Novavax Inc (NVAX.O), the companies said on Friday, improving the number of deals it has with drugmakers as the global fax race draws to a close. FILE PHOTO: The company logo for Johnson …
Read More »Exclusive: FS to create coronavirus strain for possible trials with human challenge
CHICAGO (Reuters) – U.S. government scientists have begun efforts to create a strain of the new coronavirus that could be used in human challenge tests of vaccines, a controversial type of study in which healthy volunteers would vaccinate and then deliberately infect with the virus, Reuters has learned. FILE PHOTO: …
Read More »Novavax delivers 60 million doses of COVID-19 vaccine candidate to UK
(Reuters) – US drug developer Novavax Inc said on Friday that the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373. FILE PHOTO: A woman holds a small bottle labeled “Vaccine COVID-19” and a medical syringe in this illustration April 10, 2020. REUTERS / Dado Ruvic / …
Read More »